A: Sometimes the body may not be able to tolerate the full dose due to side effects
In fact, heart failure specialists and cardiology guidelines now mention GLP-1 RAs as part of glucose management in diabetics with heart disease, and they highlight their weight and blood pressure lowering
Finally, many people experience natural weight loss patterns characterised by periods of steady loss followed by plateaus, then further loss
Therefore, It is best to seek advice from a qualified healthcare professional who can offer guidance based on your specific health before using IGF-1 LR3 or any other peptide
Clinical data in humans remain limited, highlighting the need for further well-designed clinical research to establish both safety and efficacy
Lead author John Deanfield, professor of cardiology at the UCL Institute of Cardiovascular Science, said: Abdominal fat is more dangerous for our cardiovascular health than overall weight, and therefore it is not surprising to see a link between reduction in waist size and cardiovascular benefit